Capecitabine‐containing regimens vs chemotherapy regimens without capecitabine
Hand‐foot syndrome · neoadjuvant treatment of ER‐positive vs ER‐negative breast cancer
Capecitabine‐containing regimens probably leads to higher hand‐foot syndrome compared with non‐capecitabine‐containing regimens (moderate certainty).
1 finding from 1 review
- Capecitabine for hormone receptor‐positive versus hormone receptor‐negative breast cancer 2021 · Cochrane Headline outcomes onlyOR 6.77 [4.89, 9.38]5 studies · 3021 participantsModerate